Genetic Testing Services Market to Witness Huge Growth in 2025 | Key Player Analysis: F. Hoffmann-La Roche Ltd., Illumina, Inc., Quest Diagnostics Incorporated, Genomic Health, Inc., NeoGenomics Laboratories
Genetic Testing Services Market- Global Analysis and Forecasts by Test Type (Prenatal Testing, Newborn Screening, Predictive & Presymptomatic Testing, and Pharmacogenomic Testing), Application (Oncology, Autoimmune Diseases and Infectious Diseases) Service Provider (Hospital-based Laboratories, Diagnostic Laboratories, and Specialty Clinics)
Genetic testing is a process of analysis of human DNA in any of its form or related products such as RNA, chromosomes, DNA and others. Genetic testing is widely used for detection of diseases that are related to genotype, phenotype or mutation. Genetic testing is performed on tumors to diagnose cancer and plan the treatment. The major types of genetic testing are newborn screening, prenatal testing, pre-implantation testing, carrier testing, etc. Genetic testing is employed to identify the risk factors, to screen the newborns, and also in forensics.
Get Genetic Testing Services Market report sample @ http://bit.ly/2zwDGqi
The Report Aims to provide an overview of global orthobiologics market with detailed market segmentation by test type, application, and service provider. The global orthobiologics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the orthobiologics market.
The Major Key Market Players:
1. Laboratory Corporation of America Holdings
2. F. Hoffmann-La Roche Ltd
3. Illumina, Inc.
4. Quest Diagnostics Incorporated
5. Genomic Health, Inc.
6. NeoGenomics Laboratories, Inc.
7. Eurofins Scientific
8. Ambry Genetics
9. CENTOGENE AG
10. 23and Me, Inc.
The "Global Genetic Testing Services Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global genetic testing services market with detailed market segmentation by test type, application, service provider, and geography. The global genetic testing services market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the genetic testing services market.
The genetic testing services market is expected to grow significantly in the coming years, owing to the key factors such as, rise in demand for advanced technique for genetic testing, rise in the prevalence of cancer and cardiovascular diseases, and benefits offered by genetic testing during the forecast period. In addition, government initiatives and increased R&D activities in the field are likely to propel the opportunities for the market players to develop more advanced products in the forecasted period.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global genetic testing services market based on test type, application, and service provider. It also provides market size and forecast till 2025 for overall genetic testing services market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The genetic testing services market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
Also, key Genetic Testing Services Market players influencing the market are profiled in the study along with their SWOT analysis and market strategies. The report also focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.
Buy the complete report with Comprehensive table of contents @ http://bit.ly/2rf2MWe
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.
The Insight partners,
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Genetic Testing Services Market to Witness Huge Growth in 2025 | Key Player Analysis: F. Hoffmann-La Roche Ltd., Illumina, Inc., Quest Diagnostics Incorporated, Genomic Health, Inc., NeoGenomics Laboratories here
News-ID: 1409132 • Views: 865
More Releases from The Insight Partners
Artificial Intelligence in Supply Chain Market Outlook to 2027 with Top Key Play …
“Worldwide Artificial Intelligence in Supply Chain Market Analysis 2019-2027″ is a specialized and in-depth study of the technology industry focusing on the global market trend. The report aims to provide an overview of the global Artificial Intelligence in Supply Chain Market with detailed market segmentation by type, application and geography. The global market for Artificial Intelligence in Supply Chain Market is expected to grow strongly in the forecasting period. The
Cognitive Robotic Process Automation Market Future Trends to 2027 - IPsoft, Veri …
According to a new market study entitled "Cognitive Robotic Process Automation Market to 2027 - Global Analysis and Forecasts by Deployment Type (On-Premise and Cloud) and Industry Vertical (BFSI, Healthcare & Life Sciences, Retail & Consumer Goods, Manufacturing, Travel & Hospitality, IT & Telecommunication, Media & Entertainment, and Others) and Geography, "explains the report, explaining the key drivers of this growth and highlighting key market players and their evolution. The
Allergy Immunotherapy Market Competitive Dynamics and Business Outlook 2027 | Ci …
Allergy Immunotherapy Market: Introduction and Dynamics Allergy Immunotherapy Market concludes with precise and authentic market estimations considering all the parameters and market dynamics. Every crucial and decisive detail for the development and restriction of the market is mentioned in the report that may affect the market in near future. Segmentation of the market are studied specifically to give profound knowledge for supplementary market investments. The report aims to provide an overview of
Generic Drugs Market 2019 Statistic Competitive Landscape Forecast to 2027 With …
The “The Insight Partners “ market research report provides a comprehensive picture on “Generic Drugs Market”, from the global viewpoint, offering a forecast and statistic in terms of revenue during the forecast period. The report covers a descriptive analysis with detailed segmentation, complete research and development history, latest news and press releases. Furthermore, the study explains the future opportunities and a sketch of key players operating in the “Generic Drugs
More Releases for Genetic
Preimplantation Genetic Diagnosis: Scope & Revenue Outlook
Rising numbers of assisted reproductive procedures such as in vitro fertilization (IVF) is Asia is the most prominent factor driving the market for preimplantation genetic diagnosis. This is, in essence, the result of factors such as the delayed age of conception among Asian women, the rising rate of infertility among the population, and the significantly expanding medical tourism industry in the region. Rising disposable incomes and increased awareness regarding the
Preimplantation Genetic Testing Market-Size Report 2022
Preimplantation Genetic Testing Market by type 2017-2022 by new Service spreads across 204 pages profiling 17 companies and supported with 85 tables and 42 figures available at ReportsnReports.com Get sample copy for information professional insights@ http://www.reportsnreports.com/contacts/requestsample.aspx?name=1128201 “Preimplantation Genetic Testing Market projected to grow at a CAGR of 10.0%” The global preimplantation genetic testing market is expected to reach USD 541.8 million by 2022 from USD 336.4million in 2017, at a CAGR
India Genetic Testing Market Analysis
India is witnessing an accelerating shift towards the prevalence of non-communicable diseases, having secured third position in congenital malformations and genetic disorders as the commonest causes of mortality in neonates in cities. The ability to identify these non-communicable diseases at an early stage lies within the genetic screening segment. Genetic screening, however, is still in its infancy and there are many challenges that need to be overcome in order to
RBD Creative partners with Reproductive Genetic Innovations
Acknowledged in D Business' Faces of Detroit in 2015, RBD Creative, a local Plymouth marketing and design studio, is proud to announce a new partnership with Reproductive Genetic Innovations (RGI) of Northbrook, IL. RBD Creative specializes in health and wellness marketing solutions and has several notable clients including: University of Michigan Health System, University of Michigan School of Medicine, Lakes Urgent Care, Evangelical Homes of Michigan, Cryowellness USA, Michigan Reproductive
Preimplantation Genetic Diagnosis - Saving Offsprings From Any Genetic Disorder
The market for preimplantation genetic diagnosis (PGD) in Asia features high fragmentation when it comes to diagnostic service providers. The large number of local players has intensified the competitive rivalry in the region. However, owing to the lack of better alternatives to PGD, costs of these procedures remain high, a major limiting factor for the market, especially in cost-sensitive developing countries in the region. A recent report by TMR suggests that
OGT aids research into molecular genetic disease
Unique CytoSure™ Molecular Testing Arrays provide high throughput CNV detection for multiple disorders on a single chip Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today announced a new range of CytoSure™ Molecular Testing Arrays and Panels. The new DNA microarrays utilise a unique collection of probes for detecting copy number variations (CNVs) within genes associated with a variety of disorders. Three